The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease

We investigated the relationship between APOE genotype and rate of disease progression and survival in 99 patients with probable Alzheimer's disease (AD) who were followed biannually for up to 6 years. Patients were stratified into two groups, those with and without at least one APOE ϵ4 allele. The rate of decline in modified Mini‐Mental State Examination scores was slower, the presence of extrapyramidal signs was decreased, and the development of myoclonus occurred later among patients with APOE ϵ4 alleles compared with patients with other genotypes. Compared with patients with other genotypes. Compared with patients without an APOE ϵ4 allele, the risk of mortality was also decreased in patients with at least one ϵ4 allele (RR = 0.38; CI = 0.17−0.84, P < 0.02). Because the decline in mental ability as well as the development of myoclonus and extrapyramidal signs are consistent manifestations of disease progression, our results imply that APOE ϵ4 is associated with a less aggressive form of AD.

[1]  J. Hughes,et al.  Study of Alzheimer's Dementia Patients with Parkinsonian Features , 1995, Journal of geriatric psychiatry and neurology.

[2]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[3]  L. Schneider,et al.  Prognostic Implications of Symptomatic Behaviors in Alzheimer’s Disease , 1992 .

[4]  Giovanni B. Frisoni,et al.  Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease , 1995 .

[5]  W. Hauser,et al.  Predictors of disease course in patients with probable Alzheimer's disease , 1987, Neurology.

[6]  M. Finch,et al.  Predictors of cognitive and functional progression in patients with probable Alzheimer's disease , 1992, Neurology.

[7]  Norman R. Draper,et al.  Applied regression analysis (2. ed.) , 1981, Wiley series in probability and mathematical statistics.

[8]  R. Mayeux,et al.  Depression, intellectual impairment, and Parkinson disease , 1981, Neurology.

[9]  R. Reep,et al.  Manatee cerebral cortex: cytoarchitecture of the caudal region in Trichechus manatus latirostris. , 1995, Brain, behavior and evolution.

[10]  M. Albert,et al.  Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons , 1993, Alzheimer disease and associated disorders.

[11]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[12]  G. Schroth,et al.  Early diagnosis of herpes simplex encephalitis by MRI , 1987, Neurology.

[13]  R. Rosenberg.  Autosomal dominant cerebellar phenotypes , 1990, Neurology.

[14]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[15]  J. H. van der Meulen,et al.  Comorbidity and Its Effect on Mortality in Nursing Home Patients with Dementia , 1996, The Journal of nervous and mental disease.

[16]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[17]  M Richards,et al.  Subtle extrapyramidal signs can predict the development of dementia in elderly individuals , 1993, Neurology.

[18]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[19]  Yaakov Stern,et al.  Relationships between extrapyramidal signs and cognitive function in a community‐dwelling cohort of patients with Parkinson's disease and normal elderly individuals , 1993, Annals of neurology.

[20]  E. Kokmen,et al.  Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. , 1996, Journal of clinical epidemiology.

[21]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[22]  A. Hofman,et al.  The apolipoprotein E ε2 allele is associated with an increased risk of early‐onset alzheimer's disease and a reduced survival , 1995 .

[23]  J. Haines,et al.  Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease , 1995, Neurology.

[24]  K. Marder,et al.  Interrater reliability of extrapyramidal signs in a group assessed for dementia. , 1991, Archives of neurology.

[25]  R. Mayeux,et al.  Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. , 1991, Archives of neurology.

[26]  B. Tycko,et al.  Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.

[27]  W. Tsai,et al.  A functional decline model for prevalent cohort data. , 1996, Statistics in medicine.

[28]  Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. , 1995, Archives of neurology.

[29]  E. Feskens,et al.  Apolipoprotein e4 allele and cognitive decline in elderly men , 1994, BMJ.